Outcome of Board Meeting
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 10, 2012, inter alia, has approved the following:1. Ms. Jyoti Asawa Resign as a Company Secretary of the Company.2. Mr. Amarendra Mohapatra appointed as a Company Secretary and Compliance Officer of the Company. Outcome of AGM
Bliss GVS Pharma Ltd has informed BSE that the 27th Annual General Meeting (AGM) of the Company was held on August 10, 2012. (For more details kindly refer Corporate Announcements on www.bseindia.com). Financial Results & Limited Review for June 30, 2012
Bliss GVS Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2012. Resignation of Company Secretary
Bliss GVS Pharma Ltd has informed BSE that Ms. Jyoti Asawa, Company Secretary resign from the Company with immediate effect. Acquisition of Majority Stake
Bliss GVS Pharma Ltd has informed BSE that the Company has acquired 70% management stake in the Company M/s. Kremoint Pharma Private Limited. M/s. Kremoint Pharma Private Limited is into manufacturing of pharmaceuticals and a leading Company in the manufacture and export of Creams, Ointments and Gels.These acquisitions then boast the Company's strength in the manufacture and export of pharmaceuticals. Fixes Book Closure for Dividend & AGM
Bliss GVS Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 06, 2012 to August 10, 2012 (both days inclusive) for the purpose of Payment of Dividend & 27th Annual General Meeting (AGM) of the Company to be held on August 10, 2012. Outcome of Board Meeting (AGM on Aug 10, 2012)
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, has fixed the date of the 27th Annual General Meeting on August 10, 2012 at 10.00 a.m. Board recommends Dividend
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, inter alia, has approved the following;- Recommendation of 40% Dividend i.e. Rs. 0.40 per equity share for the year ended March 31, 2012. Financial Results for March 31, 2012
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the period ended March 31, 2012. Board to consider Dividend
Bliss GVS Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2012, inter alia, to consider the Audited Financial Results of the Company for the year ended March 31, 2012, and dividend, if any.